Jan Geissler: Empowering Early-Career Hematologists Through EHA’s CRTH Program
Jan Geissler, Founder and CEO of Patvocates, shared a post on LinkedIn.
“Early-career hematologists designing their first clinical studies bring something unique: they are hungry for innovation, full of ideas, super motivated, energetic, and eager to challenge the status quo in treating current hematological diseases like AML, Lymphoma, CLL and Multiple Myeloma, the European Hematology Association (EHA) has run the ‘Clinical Research Training in Hematology (CRTH)’ for quite a number of years.
CRTH is a specialized training and mentoring programme designed to help young hematologists advance their career and their knowledge in clinical science.
Scholars who have successfully applied for the programme with their clinical research project concept are attending two multi-day workshops and a training session at the EHA Congress over a duration of 9 months.
A faculty of 16 experts coach and train the 20 scholars on e.g. clinical research methodology, biostatistics, diversity in trials, digital health, trial data management, trial budgeting, career development, trial design and their own draft clinical trials — all through interactive workshops, mentoring, and plenty of open discussion (sometimes even over late-night karaoke).
For the past four years, I’ve had the privilege of serving in the faculty as the only patient advocate. This week, in a farmhouse just outside Madrid, I held a training on patient engagement in clinical trials, and engagement of patient organisations in publicly funded projects. In the September session, I will train on using PROs in hematology trials and on patient literacy about research.
Programs like CRTH create an amazing space for learning and for creating a network between the scholars which will last forever. CRTH scholars of previous years are now shaping research, publishing data, and contribute to EHA’s committees, demonstrating that this programme really has impact on advancement of science, clinical practice and research collaboration.
I am grateful to the EHA team, the inspiring faculty, and the brilliant 2026 CRTH Scholars for the chance to exchange ideas, challenge perspectives, and see the rise of a new generation of hematologists.
Specific thanks to Jennifer Scheffer, Audrey Urighe, Sirpa Leppa, Urania Dafni, Verena Gaidzik, Ron van der Holt, Oscar Brück, Marije Faber, Tarec Christoffer El-Galaly, Maaike Leidekker, Marie von Lilienfeld, Mandy L., Kate Cwynarski, Christina Yap, Charles la Porte, Amy Kirkwood, Mika Kontro and Paula Rodríguez Otero, as well to the European Hematology Association of course!”
Stay updated on all scientific advances with Hemostasis Today.
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders
-
May 23, 2026, 16:38José Octavio Alva Bucio: Securing the Future of Plasma and Blood-Derived Medicines
-
May 23, 2026, 16:33Why Are We Dismantling What Powers Humanity and the Global Economy? – ASH
-
May 23, 2026, 16:24Marc Wittwer: A Practical Viscoelastic-Guided Algorithm for Trauma-Induced Coagulopathy in Clinical Workflow